GUIDE-CAC: Statin-Ezetimibe Without Aspirin vs. Statin Monotherapy With Aspirin in High Coronary Calcification

PHASE4RecruitingINTERVENTIONAL
Enrollment

7,435

Participants

Timeline

Start Date

July 9, 2025

Primary Completion Date

June 30, 2032

Study Completion Date

October 31, 2032

Conditions
Primary PreventionVascular Calcification
Interventions
DRUG

Pitavastatin 4mg and ezetimibe 10mg, taken once daily

Intensive lipid-lowering therapy without aspirin

DRUG

Pitavastatin 2 mg with aspirin 100 mg, taken once daily.

Moderate-intensity lipid-lowering therapy with aspirin

Trial Locations (1)

Unknown

RECRUITING

Asan Medical Center, Seoul

Sponsors
All Listed Sponsors
lead

Asan Medical Center

OTHER

NCT06722521 - GUIDE-CAC: Statin-Ezetimibe Without Aspirin vs. Statin Monotherapy With Aspirin in High Coronary Calcification | Biotech Hunter | Biotech Hunter